Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Gyre Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +1 vs. Q3 2022
- Shares held
- 4.99M
- −2.74M (−35.4%) vs. Q3 2022
- Total value
- $2.63M
- −$1.26M (−32.4%) vs. Q3 2022
- New holders
- 8
- 8 more added
- Sold out
- 7
- 12 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | +4 | New |
| GWM Advisors LLC | 1 | $0 | 0.00% | +1 | New |
| Wells Fargo & Company | 180 | $95 | 0.00% | +4+2.3% | Added |
| Advisor Group Holdings, Inc. | 215 | $113 | 0.00% | +215 | New |
| BNP Paribas Arbitrage, SA | 277 | $146 | 0.00% | −44−13.7% | Reduced |
| Advisory Services Network, LLC | 1,000 | $528 | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 1,394 | $1.00K | 0.00% | −682−32.9% | Reduced |
| Cutler Group LP | 5,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 17,201 | $9.07K | 0.00% | +17,201 | New |
| Keebeck Wealth Management, LLC | 20,000 | $10.6K | 0.00% | +20,000 | New |
| Bank of America Corp | 22,550 | $11.9K | 0.00% | +66+0.3% | Added |
| Group One Trading, L.P. | 23,166 | $12.2K | 0.00% | −25,394−52.3% | Reduced |
| Barclays PLC | 30,102 | $15.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 31,303 | $16.5K | 0.00% | +31,303 | New |
| HSBC Holdings PLC | 32,528 | $17.1K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 32,520 | $17.2K | 0.00% | −13,600−29.5% | Reduced |
| Colorado Capital Management, Inc. | 34,165 | $18.0K | 0.02% | +20,453+149.2% | Added |
| Morgan Stanley | 36,009 | $19.0K | 0.00% | −98−0.3% | Reduced |
| Two Sigma Securities, LLC | 39,778 | $21.0K | 0.00% | +26,169+192.3% | Added |
| Buckingham Strategic Wealth, LLC | 43,100 | $22.7K | 0.00% | +43,100 | New |
| Lazard Asset Management LLC | 53,221 | $28.0K | 0.00% | +7,249+15.8% | Added |
| Johnson & Johnson | 66,951 | $35.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 72,599 | $38.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 86,412 | $45.6K | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 90,484 | $47.7K | 0.01% | +296+0.3% | Added |
| Virtu Financial LLC | 131,218 | $69.0K | 0.01% | −57,957−30.6% | Reduced |
| BlackRock Inc. | 179,362 | $94.6K | 0.00% | −185−0.1% | Reduced |
| Millennium Management LLC | 195,022 | $103.0K | 0.00% | −699,700−78.2% | Reduced |
| Bank of New York Mellon Corp | 200,638 | $105.8K | 0.00% | −1,508−0.7% | Reduced |
| Geode Capital Management, LLC | 274,587 | $144.0K | 0.00% | −678−0.2% | Reduced |
| Citadel Advisors LLC | 311,716 | $164.4K | 0.00% | +250,519+409.4% | Added |
| Nantahala Capital Management, LLC | 438,055 | $231.1K | 0.02% | −2,116,680−82.9% | Reduced |
| Renaissance Technologies LLC | 1,186,986 | $626.0K | 0.00% | +85,716+7.8% | Added |
| Vanguard Group Inc | 1,335,746 | $704.6K | 0.00% | −37,266−2.7% | Reduced |
| RBF Capital, LLC | 0 | $0 | 0.00% | −102,095−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −91,341−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −40,515−100.0% | Sold out |
| Stephens Inc | 0 | $0 | 0.00% | −21,525−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −20,400−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |